Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jul 22, 2026
Reporting period
Not applicable
Filed with the SEC
Jul 24, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0002028640-26-000008
Filed / recorded
Jul 24, 2026, 12:43 AM UTC
Added to OQRO
Oct 6, 2026, 9:34 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
UNITED THERAPEUTICS Corp
Issuer CIK
1082554
Ticker
UTHR
Reporting person
Jan Malcolm
Relationship
Director
Security
Restricted Stock Unit
Table
Derivative (Table II)
Transaction date
Jul 22, 2026
Transaction code
A
Shares / units
380
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
380
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
Annual non-employee director award.
Annual non-employee director awards become fully vested on the earlier to occur of (a) the one-year anniversary of the grant date; or (b) the date of the next Annual Meeting of Shareholders following the grant date. June 25, 2027 is the anticipated date of the next Annual Meeting of Shareholders.
Not applicable as restricted stock units do not have an expiration date.